Alimera Sciences, Inc.
ALIM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $5 | $17 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $35 | $20 | $19 | $17 |
| Inventory | $2 | $2 | $3 | $3 |
| Other Curr. Assets | $4 | $3 | $4 | $4 |
| Total Curr. Assets | $52 | $29 | $42 | $35 |
| Property Plant & Equip (Net) | $4 | $4 | $4 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $97 | $9 | $11 | $13 |
| Long-Term Investments | $0 | $0 | $1 | $15 |
| Tax Assets | $0 | $0 | $0 | $1 |
| Other NC Assets | $0 | $0 | $0 | -$15 |
| Total NC Assets | $101 | $13 | $16 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $154 | $43 | $59 | $51 |
| Liabilities | – | – | – | – |
| Payables | $8 | $10 | $9 | $7 |
| Short-Term Debt | $1 | $26 | $0 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $3 | $3 | $3 |
| Total Curr. Liab. | $22 | $40 | $13 | $12 |
| LT Debt | $64 | $19 | $43 | $43 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$1 |
| Other NC Liab. | $21 | $5 | $5 | $4 |
| Total NC Liab. | $85 | $24 | $49 | $46 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $1 |
| Total Liabilities | $107 | $63 | $61 | $59 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $19 | $19 | $19 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$418 | -$415 | -$397 | -$393 |
| AOCI | $2 | -$3 | -$2 | -$1 |
| Other Equity | $467 | $378 | $377 | $366 |
| Total Equity | $46 | -$21 | -$3 | -$8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $154 | $43 | $59 | $51 |
| Net Debt | $53 | $40 | $27 | $34 |